The role of CEBPα mutations in the progression of myeloid leukemias.

被引：0
|
作者：
Shih, LY
Huang, CF
Liang, DC
Lin, TL
Wu, JH
Wang, PN
Dunn, P
Kuo, MC
Tang, CC
机构：
[1] Chang Gung Mem Hosp, Div Hematol Oncol, Taipei, Taiwan
[2] Chang Gung Univ, Sch Med, Taipei, Taiwan
[3] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3004
引用
收藏
页码：821A / 821A
页数：1
相关论文
共 50 条
  • [1] Emerging role of CEBP-α mutations in acute myeloid leukemia
    Shah, Mithun Vinod
    Litzow, Mark R.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (02) : 99 - 100
  • [2] Passive and active specific immunotherapy of myeloid leukemias.
    Scheinberg, DA
    Bocchia, M
    Jurcic, J
    Caron, P
    Larson, S
    Papadopoulos, E
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 527 - 527
  • [3] Regulation of apoptosis in normal hematopoiesis and in myeloid leukemias.
    Andreeff, M
    Zhao, S
    Kliche, KO
    Jiang, S
    Consoli, U
    Lisovsky, M
    Snell, V
    Zhang, X
    SanchezWilliams, G
    Reed, J
    Estey, E
    BLOOD, 1996, 88 (10) : 314 - 314
  • [4] CEBPα mutations in childhood acute myeloid leukemia
    D -C Liang
    L -Y Shih
    C -F Huang
    I -J Hung
    C -P Yang
    H -C Liu
    T -H Jaing
    L -Y Wang
    W -H Chang
    Leukemia, 2005, 19 : 410 - 414
  • [5] CEBPα mutations in childhood acute myeloid leukemia
    Liang, DC
    Shih, LY
    Huang, CF
    Hung, IJ
    Yang, CP
    Liu, HC
    Jaing, TH
    Wang, LY
    Chang, WH
    LEUKEMIA, 2005, 19 (03) : 410 - 414
  • [6] Expression and DNAzyme targeting of the apoptosis inhibitor, survivin in myeloid leukemias.
    Tobal, K
    Kabuli, M
    Yin, JAL
    BLOOD, 2000, 96 (11) : 216A - 216A
  • [7] CEBPα mutations in childhood acute myeloid leukemia.
    Liang, DC
    Shih, LY
    Huang, CF
    Hung, IJ
    Yang, CP
    Liu, HC
    Jaing, TH
    Wang, LY
    Chang, WH
    BLOOD, 2004, 104 (11) : 821A - 821A
  • [8] Expression of the myeloperoxidase gene used as an early myeloid marker in acute leukemias.
    Crisan, D
    Mattson, JC
    BLOOD, 1995, 86 (10) : 3003 - 3003
  • [9] Analysis of lymphoid antigen expression in 271 cases of acute myeloid leukemias.
    Venditti, A
    DelPoeta, G
    Buccisano, F
    Tamburini, AA
    Bruno, A
    Cox, C
    Maffei, L
    Simeone, MD
    Amadori, S
    Papa, G
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 546 - 546
  • [10] The CLAEG-protocol: An effective treatment for high risk myeloid leukemias.
    Krieger, O
    Kasparu, H
    Girschikofsky, M
    Oppitz, P
    Bettelheim, P
    Lutz, D
    BLOOD, 1997, 90 (10) : 3835 - 3835
12345